Tapering and Discontinuation of Glucocorticoid Prophylaxis during Prolonged Weekly to Biweekly Paclitaxel Administration
- 1 May 2005
- journal article
- Published by S. Karger AG in Chemotherapy
- Vol. 51 (2-3), 116-119
- https://doi.org/10.1159/000085618
Abstract
Taxanes cause hypersensitivity reactions, averted by premedication with H1 blockers and high glucocorticoid (GC) doses. Prolonged weekly taxane administration may lead to GC toxicity. To determine whether patients not hypersensitive to initial paclitaxel (PTX) infusion after high-dose GC premedication will tolerate subsequent, prolonged PTX treatment without GC prophylaxis. In 115/122 breast cancer patients not hypersensitive to initial PTX treatment, 20 mg dexamethasone (DXM) doses were tapered by 2.0 mg/week, reaching 0 in those receiving 9 or more courses. After 4 PTX courses, diphenhydramine was administered orally, rather than intravenously. PTX was administered 143 times after 2.0-5.0 mg of DXM and 357 times without DXM. A total of 46 patients received 1-40 PTX courses without DXM. None of these 115 patients experienced hypersensitivity reactions. Patients unreactive to their first PTX infusions, after high-dose and tapering GC premedication, may not require GC prophylaxis for subsequent PTX therapy.Keywords
This publication has 16 references indexed in Scilit:
- Pharmacokinetics, Safety, and Efficacy of Trastuzumab Administered Every Three Weeks in Combination With PaclitaxelJournal of Clinical Oncology, 2003
- Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast CancerJournal of Clinical Oncology, 2003
- A Comparison of Two Prophylactic Regimens for Hypersensitivity Reactions to PaclitaxelGynecologic Oncology, 2002
- Premedication Strategy for Weekly PaclitaxelCancer Investigation, 2002
- Hypersensitivity Reactions and the Utility of Oral and Intravenous Desensitization in Patients with Gynecologic MalignanciesGynecologic Oncology, 2001
- An effective and more convenient drug regimen for prophylaxis gainst paclitaxel-associated hypersensitivity reactionsZeitschrift für Krebsforschung und Klinische Onkologie, 1999
- Single-Dose Dexamethasone Paclitaxel PremedicationGynecologic Oncology, 1998
- Rapid intravenous premedication with dexamethasone prevents hypersensitivity reactions to paclitaxelAnnals Of Oncology, 1996
- Paclitaxel Premedication RegimensJNCI Journal of the National Cancer Institute, 1996
- Successful parenteral desensitization to paclitaxelJournal of Allergy and Clinical Immunology, 1996